Literature DB >> 22937990

Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions.

Kyaw-Zeyar Myint1, Lirong Wang, Qin Tong, Xiang-Qun Xie.   

Abstract

In this manuscript, we have reported a novel 2D fingerprint-based artificial neural network QSAR (FANN-QSAR) method in order to effectively predict biological activities of structurally diverse chemical ligands. Three different types of fingerprints, namely, ECFP6, FP2 and MACCS, were used in FANN-QSAR algorithm development, and FANN-QSAR models were compared to known 3D and 2D QSAR methods using five data sets previously reported. In addition, the derived models were used to predict GPCR cannabinoid ligand binding affinities using our manually curated cannabinoid ligand database containing 1699 structurally diverse compounds with reported cannabinoid receptor subtype CB(2) activities. To demonstrate its useful applications, the established FANN-QSAR algorithm was used as a virtual screening tool to search a large NCI compound database for lead cannabinoid compounds, and we have discovered several compounds with good CB(2) binding affinities ranging from 6.70 nM to 3.75 μM. To the best of our knowledge, this is the first report for a fingerprint-based neural network approach validated with a successful virtual screening application in identifying lead compounds. The studies proved that the FANN-QSAR method is a useful approach to predict bioactivities or properties of ligands and to find novel lead compounds for drug discovery research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22937990      PMCID: PMC3462244          DOI: 10.1021/mp300237z

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  55 in total

Review 1.  Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.

Authors:  Roger Perkins; Hong Fang; Weida Tong; William J Welsh
Journal:  Environ Toxicol Chem       Date:  2003-08       Impact factor: 3.742

2.  A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES.

Authors:  S M FREE; J W WILSON
Journal:  J Med Chem       Date:  1964-07       Impact factor: 7.446

3.  Data mining a small molecule drug screening representative subset from NIH PubChem.

Authors:  Xiang-Qun Xie; Jian-Zhong Chen
Journal:  J Chem Inf Model       Date:  2008-02-27       Impact factor: 4.956

4.  Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.

Authors:  Qi-Shi Du; Ri-Bo Huang; Yu-Tuo Wei; Zong-Wen Pang; Li-Qin Du; Kuo-Chen Chou
Journal:  J Comput Chem       Date:  2009-01-30       Impact factor: 3.376

5.  Machine learning study for the prediction of transdermal peptide.

Authors:  Eunkyoung Jung; Seung-Hoon Choi; Nam Kyung Lee; Sang-Kee Kang; Yun-Jaie Choi; Jae-Min Shin; Kihang Choi; Dong Hyun Jung
Journal:  J Comput Aided Mol Des       Date:  2011-03-30       Impact factor: 3.686

6.  1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.

Authors:  I K Khanna; R M Weier; Y Yu; X D Xu; F J Koszyk; P W Collins; C M Koboldt; A W Veenhuizen; W E Perkins; J J Casler; J L Masferrer; Y Y Zhang; S A Gregory; K Seibert; P C Isakson
Journal:  J Med Chem       Date:  1997-05-23       Impact factor: 7.446

7.  3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.

Authors:  Jian-Zhong Chen; Xiu-Wen Han; Qian Liu; Alexandros Makriyannis; Junmei Wang; Xiang-Qun Xie
Journal:  J Med Chem       Date:  2006-01-26       Impact factor: 7.446

8.  Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.

Authors:  A Gangjee; A P Vidwans; A Vasudevan; S F Queener; R L Kisliuk; V Cody; R Li; N Galitsky; J R Luft; W Pangborn
Journal:  J Med Chem       Date:  1998-08-27       Impact factor: 7.446

9.  1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents.

Authors:  J J Li; G D Anderson; E G Burton; J N Cogburn; J T Collins; D J Garland; S A Gregory; H C Huang; P C Isakson; C M Koboldt
Journal:  J Med Chem       Date:  1995-10-27       Impact factor: 7.446

10.  Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives.

Authors:  H Sugimoto; Y Tsuchiya; H Sugumi; K Higurashi; N Karibe; Y Iimura; A Sasaki; S Araki; Y Yamanishi; K Yamatsu
Journal:  J Med Chem       Date:  1992-11-27       Impact factor: 7.446

View more
  19 in total

Review 1.  Open-source chemogenomic data-driven algorithms for predicting drug-target interactions.

Authors:  Ming Hao; Stephen H Bryant; Yanli Wang
Journal:  Brief Bioinform       Date:  2019-07-19       Impact factor: 11.622

2.  Ligand biological activity predictions using fingerprint-based artificial neural networks (FANN-QSAR).

Authors:  Kyaw Z Myint; Xiang-Qun Xie
Journal:  Methods Mol Biol       Date:  2015

3.  Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers.

Authors:  Yuemin Bian; Yankang Jing; Lirong Wang; Shifan Ma; Jaden Jungho Jun; Xiang-Qun Xie
Journal:  Mol Pharm       Date:  2019-05-03       Impact factor: 4.939

4.  Consensus models for CDK5 inhibitors in silico and their application to inhibitor discovery.

Authors:  Jiansong Fang; Ranyao Yang; Li Gao; Shengqian Yang; Xiaocong Pang; Chao Li; Yangyang He; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2014-12-16       Impact factor: 2.943

Review 5.  Machine learning in chemoinformatics and drug discovery.

Authors:  Yu-Chen Lo; Stefano E Rensi; Wen Torng; Russ B Altman
Journal:  Drug Discov Today       Date:  2018-05-08       Impact factor: 7.851

6.  Trisubstituted Sulfonamides: a New Chemotype for Development of Potent and Selective CB2 Receptor Inverse Agonists.

Authors:  Qin Ouyang; Qin Tong; Rentian Feng; Kyaw-Zeyar Myint; Peng Yang; Xiang-Qun Xie
Journal:  ACS Med Chem Lett       Date:  2013-04-11       Impact factor: 4.345

Review 7.  Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era.

Authors:  Yankang Jing; Yuemin Bian; Ziheng Hu; Lirong Wang; Xiang-Qun Xie
Journal:  AAPS J       Date:  2018-03-30       Impact factor: 4.009

8.  Boosting Tree-Assisted Multitask Deep Learning for Small Scientific Datasets.

Authors:  Jian Jiang; Rui Wang; Menglun Wang; Kaifu Gao; Duc Duy Nguyen; Guo-Wei Wei
Journal:  J Chem Inf Model       Date:  2020-02-03       Impact factor: 4.956

9.  Analysis of substance use and its outcomes by machine learning I. Childhood evaluation of liability to substance use disorder.

Authors:  Yankang Jing; Ziheng Hu; Peihao Fan; Ying Xue; Lirong Wang; Ralph E Tarter; Levent Kirisci; Junmei Wang; Michael Vanyukov; Xiang-Qun Xie
Journal:  Drug Alcohol Depend       Date:  2019-10-22       Impact factor: 4.492

10.  Improving quantitative structure-activity relationship models using Artificial Neural Networks trained with dropout.

Authors:  Jeffrey Mendenhall; Jens Meiler
Journal:  J Comput Aided Mol Des       Date:  2016-02-01       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.